Page last updated: 2024-10-30

metaproterenol and Patency of the Ductus Arteriosus

metaproterenol has been researched along with Patency of the Ductus Arteriosus in 1 studies

Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reale, A1

Other Studies

1 other study available for metaproterenol and Patency of the Ductus Arteriosus

ArticleYear
Evaluation of the contractile state of the human heart from the first derivative of the apexcardiogram.
    Circulation, 1967, Volume: 36, Issue:6

    Topics: Aortic Valve; Blood Pressure; Bronchodilator Agents; Coronary Disease; Ductus Arteriosus, Patent; El

1967